A comparison of A103 and inhibin reactivity in adrenal cortical tumors: Distinction from hepatocellular carcinoma and renal tumors

Modern Pathology

Volumn 11, Issue 12, 1998, Pages 1160-1164

  Renshaw, Andrew A ^a   Granter, Scott R ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

A103; Adrenal neoplasms; Hepatocellular carcinoma; Immunohistochemistry; Inhibin; Liver neoplasm; Renal neoplasms

Indexed keywords

AVIDIN; BIOTIN; INHIBIN A; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY A103; UNCLASSIFIED DRUG;

ADRENAL CORTEX ADENOMA; ADRENAL CORTEX CARCINOMA; ADRENAL CORTEX TUMOR; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; KIDNEY TUMOR; LIVER CELL CARCINOMA; ONCOCYTOMA; PRIORITY JOURNAL;

ADENOMA; ADENOMA, OXYPHILIC; ADRENAL CORTEX NEOPLASMS; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; CARCINOMA, HEPATOCELLULAR; CARCINOMA, RENAL CELL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; INHIBINS; KIDNEY NEOPLASMS; LIVER NEOPLASMS; MALE; NEOPLASM PROTEINS; SENSITIVITY AND SPECIFICITY;

EID: 0032430374     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. DeLellis RA. The adrenal gland. In: Sternberg SS, editor. Diagnostic surgical pathology. Vol 1. New York: Raven; 1994. p. 582-3.
2. Wick M, Cherwitz D, McGlennen R, Dehner L. Adrenocortical carcinoma: an immunohistochemical comparison with renal cell carcinoma. Am J Pathol 1986;122:343-52.
3. Cote R, Cordon-Cardo C, Reuter V, Rosen P. Immunopathology of adrenal and renal cortical tumors. Am J Pathol 1990; 136:1077-84.
4. Gaffey M, Traweek S, Mills S, Travis W, Lack E, Medeiros L, et al. Cytokeratin expression in adrenocortical neoplasia. Hum Pathol 1992;23:144-53.
5. Balaton AJ, Nehama-Sibony M, Callard P, Baviera EE. Distinction between hepatocellular carcinoma, cholangiocarcinoma, and metastatic carcinoma based on immunohistochemical staining for carcinoembryonic antigen and for cytokeratin 19 on paraffin sections. J Pathol 1988;156:305-10.
6. Sheahan K, O'Brien MJ, Burke B, Dervan PA, O'Keane JC, Gottlieb LS, et al. Differential reactivities of carcinoembryonic antigen (CEA) and CEA-related monoclonal and polyclonal antibodies in common epithelial malignancies. Am J Clin Pathol 1990;94:157-64.
7. Busam KJ, Iversen K, Coplan KA, Old LJ, Stockert E, Chen YT, et al. Immunoreactivity for A103, an antibody to Melan-A (Mart-1) in adrenal cortical and other steroid tumors. Am J Surg Pathol 1998;22:57-63.
8. Chivite A, Matias-Guiu X, Pons C, Algaba F, Prat J. Inhibin A expression in adrenal neoplasms. Appl Immunohistochem 1998;6:42-9.
9. Flemming P, Wellmann A, Maschek H, Lang H, Georgii A. Monoclonal antibodies against inhibin represent key markers of adult granulosa cell tumors of the ovary even in their metastases. Am J Surg Pathol 1995;19:927-30.
10. Flemming P, Grothe W, Maschek H, Petry KU, Wellmann A, Georgii A. The site of inhibin production in ovarian neoplasms. Histopathology 1996;29:465-8.
11. Rishi M, Howard LN, Bratthauer GL, Tavassoli FA. Use of monoclonal antibody against human inhibin as a marker for sex cord stromal tumors of the ovary. Am J Surg Pathol 1997;21:583-9.
12. McCluggage WG, Maxwell P, Patterson A, Sloan JM. Immunohistochemical staining of hepatocellular carcinoma with monoclonal antibody against inhibin. Histopathology 1997; 30:518-22.
13. Iezzoni JC, Mills SE, Pelkey TJ, Stoler MH. Immunohistochemical negativity of hepatocellular carcinoma [abstract]. Mod Pathol 1998;11:153A.
14. Chen YT, Stockert E, Jungbluth A, Tsang S, Coplan KA, Scanlan MJ, et al. Serological analysis of Melan-A (MART-1), a melanocyte-specific protein homogenously expressed in human melanomas. Proc Natl Acad Sci U S A 1996;93:5915-9.
15. Kawakami Y, Eliyahu S, Delgado CH, Robbins PF, Rivoltini L, Topalian SL, et al. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating tumor. Proc Natl Acad Sci U S A 1994;91:6458-62.
16. Coulie PG, Brichard V, van Pel A, Wolfel T, Schneider J, Traversari C, et al. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med 1994;180:35-42.